Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
Weatherald J, Boucly A, Chemla D, Savale L, Peng M, Jevnikar M, Jaïs X, Taniguchi Y, O'Connell C, Parent F, Sattler C, Hervé P, Simonneau G, Montani D, Humbert M, Adir Y, Sitbon O. Weatherald J, et al. Among authors: sattler c. Circulation. 2018 Feb 13;137(7):693-704. doi: 10.1161/CIRCULATIONAHA.117.029254. Epub 2017 Oct 25. Circulation. 2018. PMID: 29070502 Clinical Trial.
Pathogenesis of pulmonary arterial hypertension: lessons from cancer.
Guignabert C, Tu L, Le Hiress M, Ricard N, Sattler C, Seferian A, Huertas A, Humbert M, Montani D. Guignabert C, et al. Among authors: sattler c. Eur Respir Rev. 2013 Dec;22(130):543-51. doi: 10.1183/09059180.00007513. Eur Respir Rev. 2013. PMID: 24293470 Free PMC article. Review.
Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension.
Ricard N, Tu L, Le Hiress M, Huertas A, Phan C, Thuillet R, Sattler C, Fadel E, Seferian A, Montani D, Dorfmüller P, Humbert M, Guignabert C. Ricard N, et al. Among authors: sattler c. Circulation. 2014 Apr 15;129(15):1586-97. doi: 10.1161/CIRCULATIONAHA.113.007469. Epub 2014 Jan 30. Circulation. 2014. PMID: 24481949
[Pulmonary hypertension in liver diseases].
Savale L, Sattler C, Sitbon O. Savale L, et al. Among authors: sattler c. Presse Med. 2014 Sep;43(9):970-80. doi: 10.1016/j.lpm.2014.07.010. Epub 2014 Aug 20. Presse Med. 2014. PMID: 25148949 Review. French.
Pulmonary arterial hypertension in patients treated with interferon.
Savale L, Sattler C, Günther S, Montani D, Chaumais MC, Perrin S, Jaïs X, Seferian A, Jovan R, Bulifon S, Parent F, Simonneau G, Humbert M, Sitbon O. Savale L, et al. Among authors: sattler c. Eur Respir J. 2014 Dec;44(6):1627-34. doi: 10.1183/09031936.00057914. Epub 2014 Oct 16. Eur Respir J. 2014. PMID: 25323231 Free article.
Atypical vasculitis mimicking chronic thromboembolic pulmonary hypertension.
Dion J, Terrier B, Jaïs X, Mehdaoui A, Sattler C, Amar D, Cohen P, Guillevin L, Mouthon L; French Vasculitis Study Group (FVSG). Dion J, et al. Among authors: sattler c. Am J Med. 2015 Oct;128(10):e47-9. doi: 10.1016/j.amjmed.2015.05.028. Epub 2015 Jun 10. Am J Med. 2015. PMID: 26071824 No abstract available.
Initial dual oral combination therapy in pulmonary arterial hypertension.
Sitbon O, Sattler C, Bertoletti L, Savale L, Cottin V, Jaïs X, De Groote P, Chaouat A, Chabannes C, Bergot E, Bouvaist H, Dauphin C, Bourdin A, Bauer F, Montani D, Humbert M, Simonneau G. Sitbon O, et al. Among authors: sattler c. Eur Respir J. 2016 Jun;47(6):1727-36. doi: 10.1183/13993003.02043-2015. Epub 2016 Mar 17. Eur Respir J. 2016. PMID: 26989105 Free article.
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.
Guignabert C, Phan C, Seferian A, Huertas A, Tu L, Thuillet R, Sattler C, Le Hiress M, Tamura Y, Jutant EM, Chaumais MC, Bouchet S, Manéglier B, Molimard M, Rousselot P, Sitbon O, Simonneau G, Montani D, Humbert M. Guignabert C, et al. Among authors: sattler c. J Clin Invest. 2016 Sep 1;126(9):3207-18. doi: 10.1172/JCI86249. Epub 2016 Aug 2. J Clin Invest. 2016. PMID: 27482885 Free PMC article. Clinical Trial.
Novel targets of omalizumab in asthma.
Sattler C, Garcia G, Humbert M. Sattler C, et al. Curr Opin Pulm Med. 2017 Jan;23(1):56-61. doi: 10.1097/MCP.0000000000000340. Curr Opin Pulm Med. 2017. PMID: 27798419 Review.
[New drugs for severe asthma].
Sattler C, Malrin R, Garcia G, Humbert M. Sattler C, et al. Presse Med. 2016 Nov;45(11):1043-1055. doi: 10.1016/j.lpm.2016.09.012. Epub 2016 Nov 9. Presse Med. 2016. PMID: 27836376 Review. French.
197 results